Ken Fisher

Ken Fisher

Last Update: 07-17-2015

Number of Stocks: 592
Number of New Stocks: 57

Total Value: $49,932 Mil
Q/Q Turnover: 5%

Countries: USA CAN
Details: Top Buys | Top Sales | Top Holdings  Embed:

Ken Fisher Watch

  • This Correction Is a Lot Like 1997 – Ken Fisher

    Ken Fisher (Trades, Portfolio) thinks it is virtually impossible to time a correction.

    While history doesn't repeat itself, it often rhymes, and Fisher thinks the current correction is much like the 1997 correction.

    Since we are already well into this correction, chances are it will likely be over as fast as it started.

    Fisher then goes on to compare the current correction with the Asian Contagion of 1997/1998.


  • Undervalued Stocks Among Mario Gabelli's Recent Buys

    Mario Gabelli (Trades, Portfolio) is the founder, chairman and CEO of Gabelli Asset Management Company Investors (GAMCO Investors) and at the end of the last quarter, his portfolio was composed of 834 stocks with a total value of $18.5 billion.

    According to GuruFocus' All-In-One screener, the following are the companies he recently bought with a wide margin of safety.


  • Why Ken Fisher Is Buying Black Rock Inc.

    During the last quarter, investor Ken Fisher (Trades, Portfolio) with his Fisher Asset Management’s fund, increased by 147.95% his stake in Black Rock Inc. (BLK), and now he holds 87,758 shares and is the third main holder of the company.

    The company


  • Madison Street Partners Buys Citigroup and Morgan Stanley

    Madison Street Partners LLC is a hedge fund based in Colorado founded by Steven Owsley in 2004. Its portfolio reported a total value of its portfolio of $74 million, with a decrease of 24% since the previous quarter. During 2015, Q2, it bought 20 new stocks and increased four of its existing stakes. The following are the most heavily weighted buys during the quarter.


  • JPMorgan Chase: A Solid Bet at the Moment

    JPMorgan Chase & Co. (NYSE:JPM) is a $238.04 billion market cap company, in which Stanley Druckenmiller (Trades, Portfolio), Ken Heebner (Trades, Portfolio) and Tom Gayner (Trades, Portfolio) have initiated new positions. In the second quarter, they bought 777,300, 570,000 and 85,000 new shares, respectively.

    Estimated Return


  • Valeant Pharmaceuticals' New Female Drug

    Valeant Pharmaceuticals (NYSE:VRX) has confirmed that it will pay $1.0 billion to buy Sprout Pharmaceuticals, the closely held company that has just won U.S. approval to sell the first drug that aims to increase women 's libido. Under the terms of the agreement, which echoes The Wall Street Journal, Valeant will pay $ 500 million in cash upfront and pay the other party early next year, whose pink pills, known as “female Viagra,” will be sold under the name Addyi. The deal is scheduled to close in the third quarter.

    Other acquisitions


  • Strong Dollar Impacted Harley-Davidson's Performance

    In this article, let's take a look at Harley-Davidson, Inc. (NYSE:HOG), a $12.06 billion market cap company, which is a leading maker of heavyweight motorcycles, and also produces a line of motorcycle parts and accessories.

    Reduction in revenue


  • Cablevision Surpasses Estimates and Delivers Attractive Return

    In this article, let's take a look at Cablevision Systems Corporation (NYSE:CVC), a $7.78 billion market cap company, which is one of the largest U.S. cable multiple system operator, it offers Optimum brand cable, Internet and voice services to about 3 million subscribers in the New York tri-state area.

    The company reported higher-than-expected results in the second quarter of 2015. Net income from continuing operations was $75.6 million or $0.27 per share compared with $94.2 million or $0.34 per share in the year ago quarter. EPS outpaced analyst´s estimates of $0.24. Total revenue was at $1,653.4 million beating analyst´s estimates of $1,648 million and up 1.6% year over year. By segments, the cable segment’s revenues were $1,481.1 million, up 1.8% year over year and were divided like this:


  • One Capital Management Cuts Stake in General Electric

    At the end of the second quarter of 2015, the hedge fund One Capital Management reported a total value of its portfolio of $348,999,000 with an increase of 4.90% over the previous quarter.

    During Q2 2015, the hedge-fund sold out 12 stocks and reduced 31 stakes, and the following are the most heavily weighted sales.


  • Hedge Fund Billionaire Bill Ackman's Move on Global Snack Food Company

    Mondelez International, Inc. (NASDAQ:MDLZ) jumped more than 7% in premarket trading after activist investor Bill Ackman (Trades, Portfolio) said he would pay approximately $5.5 billion for a 7.5% stake in the maker of Oreo cookies and Ritz crackers, buying about 120.3 million shares.

    The $74.59 billion market cap company also has another activist as a major shareholder: Nelson Peltz´s Trian Partners held 48.02 million shares valued at $1.73 billion at the end of March.


  • AIG Would Yield 1.8% if the Share Price Stays at Current Levels

    American International Group (NYSE:AIG) more than doubled its quarterly dividend to $0.28 from $0.125 a share. This way, the stock would yield 1.8% if the share price stays at current levels, 100 basis points higher than the actual level. The dividend is payable on September 28 to stockholders of record at the close of business on September 14.

    Further, the company also announced it will buy back up to $5 billion more of its common stock. Year to date, the giant insurer bought $4.7 billion of stock. AIG is funding these politics from asset sales, the company has divested in non-core assets. Moreover, the company beats Q2 EPS ($1.32 vs. $1.23 estimates) and achieved higher revenues ($15.7 billion vs. $14.48 billion), but shares were trading lower by 3% on yesterday´s trading session.


  • Mondelez's EPS Decline on Sluggish Sales

    In this article, let's take a look at Mondelez International, Inc. (NASDAQ:MDLZ), a $73.48 billion market cap company, which is a global snack food company.

    Louis Moore Bacon (Trades, Portfolio) is an American hedge fund manager and trader who focuses on a global macro strategy to invest in the markets. This strategy focuses on indices, currencies, commodities and other asset classes based on expectations about specific markets and asset classes. They had their second consecutive month of net inflows in May. Although funds for $1.6 billion were added during the month, it was not enough to bring the flows to positive territory considering the entire year.


  • Warren Buffett's Bullish Stake in Costco

    In this article, let's take a look at Costco Wholesale Corporation (NASDAQ:COST), a $63.95 billion market cap company, which operates about 679 membership warehouses in the U.S., and other countries such as Puerto Rico, Canada, the U.K., Taiwan, Japan, Korea, Mexico and Australia.

    Expanding its business


  • Ken Fisher Continues To Increase Stake In ICICI Bank

    ICICI Bank (NYSE:IBN), which is India’s largest private sector bank, has witnessed strong buying interest from Ken Fisher (Trades, Portfolio). According to Fisher’s latest filing on June 20, 2015, the legendary investor’s holds 10,255,919 shares of ICICI Bank, representing a 27.9% increase in holding as compared to the last filing in March 2015. Investors can track these Guru stock actions in Real Time Alerts by Guru Focus.

    In this article, I will discuss the reasons for my bullish view on ICICI Bank for the long term. I believe that ICICI Bank is one of the best investment options in the banking sector at this point in time. However, the investment horizon needs to be for 3-5 years if investors are looking for stellar returns.


  • Ken Fisher for Forbes - Five Ways to Win From Money Losers

    “Always” is always a dangerous word in investing, but here’s a good time to use it: Always own some stocks of profitless good firms. Some are turnarounds. Others fund growth through legally deductible futuristic expenses that mask profitability while avoiding taxes. Both needlessly confuse and scare off most investors, who are guided solely, mostly or too much by earnings.

    As a result, these underappreciated firms get bid up as they otherwise progress in the real-world marketplace. When I had nothing and had nothing to lose, these were the only kind I bought. While you don’t want profitless bad companies, of course, the profitless good firm is a beautiful thing to behold.


  • Merck Reports Strong Second Quarter 2015 Earnings with Improved Outlook for the Full Year

    Merck (NYSE:MRK) released its second quarter 2015 earnings on July 28. The health care company reported revenue of $9.79 billion with adjusted net income of $2.44 billion resulting in earnings per share of $0.86. Earnings per share beat analysts’ consensus estimate by $0.05; however, revenue fell just below expectations, missing analysts’ average estimate by $10 million.

    In comparison to the second quarter of 2014, revenue was down 11% from $10.93 billion and net income was also slightly lower, down 2% from $2.49 billion. Earnings per share increased from the second quarter of 2014 up 1% from $0.85.


  • Paul Singer Reduces His Position in Juniper

    Paul Singer (Trades, Portfolio) of Elliott Management recently reduced his position in Juniper Networks, Inc. (NYSE:JNPR). Singer is the founder of Elliott Management which currently manages approximately $6.8 billion in equity assets.

    On July 24 Singer sold 27,519,345 shares of Juniper from his portfolio reducing his stake to 11,721,655 shares or 4.72% of his portfolio. After the sell his weighting in technology was reduced to 26.41% with his largest technology holding in EMC Corporation (NYSE:EMC).


  • Pfizer Increases Annual Earnings Guidance for 2015

    Pfizer, Inc. (NYSE:PFE) reported its second-quarter 2015 earnings on July 28. For the quarter, revenue was $11.85 billion versus analysts’ average estimate of $11.42 billion. Earnings per share of $0.56 also beat analysts’ earnings per share consensus estimate by $0.04. Overall, earnings for the quarter lagged slightly from the second quarter of 2014 with total revenue down 7% from the comparable quarter and earnings per share down 3.5%. However, an improved outlook for the second half of 2015 led management to increase its annual revenue and earnings per share guidance for the year.

    The downturn in total revenue for the second quarter was primarily attributed to sales from the firm’s Established Products business segment which fell 22% from the comparable quarter to $5.09 billion. The firm operates within two business segments which include Established Products and Innovative Products. In Innovative Products Pfizer grew operational revenue by 17% for a total increase of 8%. Revenue in Innovative Products totaled $6.63 billion of which the majority was generated from the firm’s Global Innovative Pharma division which accounted for 53% of revenue at $3.50 billion. Sales growth in Innovative Products for the quarter was driven by Global Vaccines and Global Oncology which increased revenue by 44% and 25%, respectively.


  • Aerospace And Defense's Stocks With Lowest P/E

    Recently, GuruFocus introduced a new page that summarizes each industry’s ratios. According to that page, the Aerospace and Defense industry has a median P/E of 20.90 and the following are the biggest companies (based on market cap) that are trading with the lowest P/E ratio.

    United Technologies Corp (UTX)


  • Yelp Shares Tumbling After Q2 Performance

    Ken Griffin´s Citaldel Investment Group upped by 432% his position in Yelp Inc. (NYSE:YELP) to $32.8 million, according to the fund's latest filing. Further, Ken Fisher (Trades, Portfolio) has taken a long position in the stock, initiating a new position with 106,900 shares.

    Despite this bullish sentiment, Yelp shares dipped 23% to $25.80 in pre-hours trading after the company beat Q2 revenue estimates but missed on EPS and lowered its revenue guidance for the year, citing slower sales headcount growth and the elimination of its brand-advertising product.


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)